Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
medical procedure
|
gptkbp:advantage |
precise margin control
high cure rate tissue sparing |
gptkbp:alternativeName |
gptkb:Mohs_surgery
chemosurgery |
gptkbp:anesthesia |
local anesthesia
|
gptkbp:certification |
American College of Mohs Surgery
American Society for Mohs Surgery |
gptkbp:complication |
bleeding
infection nerve damage scarring |
gptkbp:contraindication |
certain melanoma subtypes
metastatic skin cancer |
gptkbp:coveredBy |
most health insurance plans
|
gptkbp:developedBy |
gptkb:Frederic_E._Mohs
|
gptkbp:field |
oncology
dermatology |
gptkbp:firstDescribed |
1938
|
gptkbp:followedBy |
regular skin checks
|
gptkbp:frequency |
increasing
|
gptkbp:guideline |
gptkb:National_Comprehensive_Cancer_Network
gptkb:American_Academy_of_Dermatology |
https://www.w3.org/2000/01/rdf-schema#label |
Mohs micrographic surgery
|
gptkbp:indication |
recurrent tumors
large tumors tumors in cosmetically sensitive areas tumors with ill-defined borders |
gptkbp:namedAfter |
gptkb:Frederic_E._Mohs
|
gptkbp:performedBy |
dermatologist
dermatologic surgeon |
gptkbp:region |
worldwide
|
gptkbp:restored |
may require local flap
may require skin graft |
gptkbp:setting |
outpatient
|
gptkbp:step |
microscopic examination
tumor removal tissue mapping margin assessment |
gptkbp:successRate |
up to 97% for recurrent basal cell carcinoma
up to 99% for primary basal cell carcinoma |
gptkbp:trainer |
fellowship in Mohs surgery
|
gptkbp:usedFor |
gptkb:cancer
gptkb:dermatofibrosarcoma_protuberans basal cell carcinoma skin cancer treatment melanoma in situ |
gptkbp:bfsParent |
gptkb:Cutaneous_Squamous_Cell_Carcinoma
|
gptkbp:bfsLayer |
5
|